CD112R (PVRIG), Fc-Fusion, Avi-Tag (Human) HiP™ Recombinant

Catalog #
79116
$320 *
Size: 100 μg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human CD112R, also known as PVRIG (Poliovirus receptor-related Immunoglobulin domain-containing protein), encompassing amino acids 41-172. This construct contains a C-terminal Human IgG1, Fc region followed by an Avi-tag. This recombinant protein was affinity purified.

Synonyms
Poliovirus Receptor-related Immunoglobulin Domain-containing Protein, Transmembrane Protein PVRIG
Product Info
Storage and Usage
Citations
Species
Human
Construct
CD112R (41-172-Fc(IgG1)-Avi)
Host Species/Expression System
HEK293
Purity

≥90%

Format
Aqueous buffer solution
Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol 

MW
42 kDa + glycans
Amino Acids
41-172
Glycosylation
This protein runs at a higher MW by SDS-PAGE due to glycosylation.
Aggregation
<10%
Genbank #
NM_024070
UniProt #
Q6DKI7
Tag(s)
C-terminal Fc-Fusion- Avi-Tag
Background

PVRIG, also known as Poliovirus receptor related immunoglobulin domain containing protein or CD112R, is a natural killer (NK) cell immune checkpoint receptor, and it is also found in CD8+ T cells. PVRIG works as an inhibitory receptor and recognizes CD112 (also known as poliovirus receptor-related 2, PVRL2 or nectin-2) as its ligand. This binding results in lower responses of NK and T cells towards cancer cells. In T cells it inhibits the nuclear factor of activated T cells (NFAT). Blocking the interaction between PVRIG and its ligand, for instance with an antibody directed towards PVRIG, represents a novel strategy in checkpoint blockade immunotherapy.

References
1. Bottino, C., et al., J. Exp. Med. 2003; 198(4): 557-567.

2. Pende, D., et al., Blood. 2005; 105(5): 2066-2073